TMDX logo

TransMedics (TMDX) EBITDA

Annual EBITDA

$69.95 M
+$77.65 M+1008.05%

December 31, 2024

Summary

Performance

1-Year Change

+1008.05%

3-Year Change

+281.74%

5-Year Change

+350.42%

15-Year Change

+466.43%

TMDX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.15%
TMDX annual EBITDA is higher than 86.15% of companies in Healthcare sector

High & Low

All-time High

$69.95 M
TMDX annual EBITDA is currently at an all-time high

3-Year Low

-$38.49 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
TMDX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
TMDX next annual earnings announcement has not yet been scheduled

OtherTMDXprofitabilitymetrics:

Annual Revenue

$441.54 M
TMDX annual revenue is $441.54 million

Annual Net Income

$35.46 M
TMDX annual net profit is $35.46 million

Annual EBIT

$50.19 M
TMDX annual earnings before interest & taxes is $50.19 million

Annual EPS

$1.07
TMDX annual earnings per share is $1.07

Quarterly EBITDA

$16.24 M
+$3.20 M+24.55%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

TMDX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.57%
TMDX quarterly EBITDA is higher than 84.57% of companies in Healthcare sector

High & Low

All-time High

$20.38 M
TMDX quarterly EBITDA is currently -20.29% below its historical high of $20.38 million

3-Year Low

-$21.45 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
TMDX previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Apr 30, 2025
TMDX next earnings announcement is scheduled for Apr 30, 2025

OtherTMDXprofitabilitymetrics:

Quarterly Revenue

$121.62 M
TMDX quarterly revenue is $121.62 million

Quarterly Net Income

$6.86 M
TMDX quarterly net profit is $6.86 million

Quarterly EBIT

$10.56 M
TMDX quarterly earnings before interest & taxes is $10.56 million

Quarterly EPS

$0.19
TMDX quarterly earnings per share is $0.19

TTM EBITDA

$69.95 M
+$5.17 M+7.98%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

TMDX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.25%
TMDX TTM EBITDA is higher than 85.25% of companies in Healthcare sector

High & Low

All-time High

$69.95 M
TMDX TTM EBITDA is currently at an all-time high

3-Year Low

-$41.55 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
TMDX previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

Apr 30, 2025
TMDX next earnings announcement is scheduled for Apr 30, 2025

OtherTMDXprofitabilitymetrics:

TTM Revenue

$441.54 M
TMDX TTM revenue is $441.54 million

TTM Net Income

$35.46 M
TMDX TTM net profit is $35.46 million

TTM EBIT

$50.19 M
TMDX TTM earnings before interest & taxes is $50.19 million

TTM EPS

$1.01
TMDX TTM earnings per share is $1.01

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$69.95 M
TMDX annual EBITDA is $69.95 million

Annual Net Income

$35.46 M
TMDX annual net profit is $35.46 million

Annual Interest Expense

$14.41 M
TMDX annual interest expense is $14.41 million

Annual Income Tax

$316.00 K
TMDX annual income tax is $316.00 thousand

Annual D&A

$19.76 M
TMDX annual depreciation & amortization is $19.76 million

TMDX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1008.0%0.0%0.0%
3 y3 years+281.7%0.0%0.0%
5 y5 years+350.4%0.0%0.0%

TMDX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+281.7%-20.3%+175.7%at high+268.4%
5 y5-yearat high+281.7%-20.3%+175.7%at high+268.4%
alltimeall timeat high+281.7%-20.3%+175.7%at high+268.4%

TransMedics EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$69.95 M(-1008.0%)
$16.24 M(+24.5%)
$69.95 M(+8.0%)
Sep 2024
-
$13.04 M(-36.0%)
$64.78 M(+113.8%)
Jun 2024
-
$20.38 M(+0.4%)
$30.30 M(+136.0%)
Mar 2024
-
$20.29 M(+83.3%)
$12.84 M(-266.6%)
Dec 2023
-$7.70 M(-73.4%)
$11.07 M(-151.6%)
-$7.70 M(-66.8%)
Sep 2023
-
-$21.45 M(-835.2%)
-$23.18 M(+210.5%)
Jun 2023
-
$2.92 M(-1281.0%)
-$7.47 M(-62.9%)
Mar 2023
-
-$247.00 K(-94.4%)
-$20.12 M(-30.5%)
Dec 2022
-$28.96 M(-24.8%)
-$4.41 M(-23.0%)
-$28.96 M(-19.0%)
Sep 2022
-
-$5.73 M(-41.1%)
-$35.76 M(-13.9%)
Jun 2022
-
-$9.73 M(+7.1%)
-$41.55 M(+1.2%)
Mar 2022
-
-$9.09 M(-18.9%)
-$41.06 M(+6.7%)
Dec 2021
-$38.49 M
-$11.21 M(-2.7%)
-$38.49 M(+19.6%)
Sep 2021
-
-$11.52 M(+24.6%)
-$32.18 M(+32.0%)
Jun 2021
-
-$9.25 M(+41.9%)
-$24.37 M(+9.6%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$6.52 M(+33.0%)
-$22.24 M(-3.9%)
Dec 2020
-$23.15 M(-17.1%)
-$4.90 M(+32.1%)
-$23.15 M(-11.0%)
Sep 2020
-
-$3.71 M(-47.9%)
-$26.00 M(-10.8%)
Jun 2020
-
-$7.12 M(-4.2%)
-$29.15 M(-2.2%)
Mar 2020
-
-$7.43 M(-4.1%)
-$29.81 M(+6.7%)
Dec 2019
-$27.93 M(+38.1%)
-$7.75 M(+13.0%)
-$27.93 M(+5.4%)
Sep 2019
-
-$6.85 M(-11.9%)
-$26.51 M(+13.0%)
Jun 2019
-
-$7.78 M(+40.3%)
-$23.46 M(+10.1%)
Mar 2019
-
-$5.55 M(-12.3%)
-$21.30 M(+5.3%)
Dec 2018
-$20.23 M(+6.0%)
-$6.33 M(+66.1%)
-$20.23 M(+45.5%)
Sep 2018
-
-$3.81 M(-32.3%)
-$13.90 M(+37.7%)
Jun 2018
-
-$5.62 M(+25.8%)
-$10.09 M(+125.8%)
Mar 2018
-
-$4.47 M
-$4.47 M
Dec 2017
-$19.09 M(-15.8%)
-
-
Dec 2016
-$22.66 M
-
-

FAQ

  • What is TransMedics annual EBITDA?
  • What is the all time high annual EBITDA for TransMedics?
  • What is TransMedics annual EBITDA year-on-year change?
  • What is TransMedics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for TransMedics?
  • What is TransMedics quarterly EBITDA year-on-year change?
  • What is TransMedics TTM EBITDA?
  • What is the all time high TTM EBITDA for TransMedics?
  • What is TransMedics TTM EBITDA year-on-year change?

What is TransMedics annual EBITDA?

The current annual EBITDA of TMDX is $69.95 M

What is the all time high annual EBITDA for TransMedics?

TransMedics all-time high annual EBITDA is $69.95 M

What is TransMedics annual EBITDA year-on-year change?

Over the past year, TMDX annual EBITDA has changed by +$77.65 M (+1008.05%)

What is TransMedics quarterly EBITDA?

The current quarterly EBITDA of TMDX is $16.24 M

What is the all time high quarterly EBITDA for TransMedics?

TransMedics all-time high quarterly EBITDA is $20.38 M

What is TransMedics quarterly EBITDA year-on-year change?

Over the past year, TMDX quarterly EBITDA has changed by $0.00 (0.00%)

What is TransMedics TTM EBITDA?

The current TTM EBITDA of TMDX is $69.95 M

What is the all time high TTM EBITDA for TransMedics?

TransMedics all-time high TTM EBITDA is $69.95 M

What is TransMedics TTM EBITDA year-on-year change?

Over the past year, TMDX TTM EBITDA has changed by $0.00 (0.00%)